Risperidon-Mepha LA 25 mg

Risperidon-Mepha LA 25 mg is a medicine authorised by Swissmedic under authorisation number 67622. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 August 2020 and the authorisation is valid without a time limit. ATC code N05AX08 places the medicine in the group Psycholeptics.

  • Dispensing category B
  • Authorisation number 67622
  • ATC N05AX08
  • Synthetic medicines
Authorisation data
Authorisation number67622
NameRisperidon-Mepha LA 25 mg
Full nameRisperidon-Mepha LA 25 mg, Pulver und Lösungsmittel zur Herstellung einer Suspension zur i.m. Injektion
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN05AX08
First authorisation13 August 2020
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Risperidon-Mepha LA 25 mg, Pulver und Lösungsmittel zur Herstellung einer Suspension zur i.m. InjektionB13 August 2020
2Risperidon-Mepha LA 37.5 mg, Pulver und Lösungsmittel zur Herstellung einer Suspension zur i.m. InjektionB13 August 2020
3Risperidon-Mepha LA 50 mg, Pulver und Lösungsmittel zur Herstellung einer Suspension zur i.m. InjektionB13 August 2020

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11SetN05AX0801.05.0.B
21SetN05AX0801.05.0.B
31SetN05AX0801.05.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Risperidon-Mepha LA 25 mg authorised in Switzerland?

Yes. Risperidon-Mepha LA 25 mg is authorised by Swissmedic under authorisation number 67622, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Risperidon-Mepha LA 25 mg have?

Risperidon-Mepha LA 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Risperidon-Mepha LA 25 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com